Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05902572
What this trial is testing

DSD Models at Zambia Sentinel Sites (SENTINEL 2)

Who this might be right for
HIV
Boston University 8,280
Large-scale testing (Phase 3)Study completedNCT02537236
What this trial is testing

Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet.

Who this might be right for
Human Immunodeficiency Virus
Instituto Mexicano del Seguro Social 200
Early research (Phase 1)Study completedNCT00002111
What this trial is testing

A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.

Who this might be right for
HIV Infections
Stanford University 32
Early research (Phase 1)Active Not RecruitingNCT03617198
What this trial is testing

CD4 CAR+ ZFN-modified T Cells in HIV Therapy

Who this might be right for
Hiv
University of Pennsylvania 12
Testing effectiveness (Phase 2)Study completedNCT01327898
What this trial is testing

Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)

Who this might be right for
HIV InfectionSubstance Abuse
Nova Southeastern University 515
Not applicableStudy completedNCT02926456
What this trial is testing

Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)

Who this might be right for
Human Immunodeficiency Virus
Janssen-Cilag S.p.A. 337
Large-scale testing (Phase 3)Study completedNCT01252212
What this trial is testing

Adherence, Improvement Measure (AIM) System

Who this might be right for
Patient ComplianceAIDS
University of California, San Francisco 99
Post-approval studies (Phase 4)Ended earlyNCT01014481
What this trial is testing

Appropriate Timing of HAART in Co-infected HIV/TB Patients

Who this might be right for
HIV InfectionsTuberculosis
Bamrasnaradura Infectious Diseases Institute 156
Testing effectiveness (Phase 2)Study completedNCT03208231
What this trial is testing

Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 61
Testing effectiveness (Phase 2)Study completedNCT03296553
What this trial is testing

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

Who this might be right for
Kaposi SarcomaHuman Immunodeficiency VirusImmune Reconstitution Syndrome
National Institute of Cancerología 40
Not applicableStudy completedNCT06969677
What this trial is testing

Personalized Normative Feedback to Increase HIV Testing

Who this might be right for
HIV TestingHIV Stigma
Massachusetts General Hospital 1,300
Not applicableWithdrawnNCT04305977
What this trial is testing

Writing to Alleviate Violence Exposure for Transgender Women (WAVE-TW)

Who this might be right for
PTSDDepressionVirus, Human Immunodeficiency
University of Miami
Large-scale testing (Phase 3)Study completedNCT02157311
What this trial is testing

4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 100
Post-approval studies (Phase 4)Study completedNCT00885664
What this trial is testing

Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection

Who this might be right for
HIV Infections
University of Cincinnati 60
Not applicableStudy completedNCT00360932
What this trial is testing

Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)

Who this might be right for
Facial Lipoatrophy
Bausch Health Americas, Inc. 290
Not applicableStudy completedNCT00002132
What this trial is testing

Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.

Who this might be right for
Candidiasis, EsophagealHIV Infections
Janssen Pharmaceuticals
Early research (Phase 1)Study completedNCT00545987
What this trial is testing

Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers

Who this might be right for
HIV Infections
Rockefeller University 40
Not applicableStudy completedNCT05938621
What this trial is testing

Estamos Juntos (We Are Together): Improving HIV Care Delivery by Capacitating Health Care Providers

Who this might be right for
Hiv
Vanderbilt University Medical Center 28,448
Early research (Phase 1)Study completedNCT04563845
What this trial is testing

Effect of Therapeutic and Supratherapeutic Oral Doses of GSK3640254 on Cardiac Conduction Compared to Placebo and a Single Oral Dose of Moxifloxacin

Who this might be right for
HIV Infections
ViiV Healthcare 50
Not applicableLooking for participantsNCT06370481
What this trial is testing

HIV, Equity, and Addiction Training (HEAT) Program

Who this might be right for
Substance Use DisordersHivOpioid Use Disorder+1 more
University of Alabama at Birmingham 30
Next Page